Stock futures rally as Nvidia’s strong forecast reignites the AI trade: Live updates

Stock futures rally as Nvidia’s strong forecast reignites the AI trade: Live updates


Traders work at the New York Stock Exchange on Nov. 19, 2025.

NYSE

Stock futures rose Thursday as investors digested Nvidia’s latest quarterly beat. The report appeared to help restore confidence in major technology stocks, providing a boost to the broader market.

Futures tied to the Dow Jones Industrial Average added 235 points, or 0.5%. S&P 500 futures rose 1.1%, while Nasdaq 100 futures jumped 1.6%.

Nvidia shares jumped nearly 5% in premarket trading after the chipmaker released its highly anticipated quarterly results, which beat Wall Street’s earnings and revenue expectations. The market-moving company also gave a stronger-than-expected fourth-quarter sales forecast, with CEO Jensen Huang saying demand for its current-generation Blackwell chips are “off the charts.” He also rejected the idea of an AI bubble.

Nvidia’s upbeat guidance likely lifted investor sentiment around the AI trade, which has weakened in recent sessions amid fears about elevated valuations, debt financing and potential chip depreciation. The results boosted a slew of stocks across the AI ecosystem in the after-hours session, including chipmakers Advanced Micro Devices and Broadcom and power infrastructure companies such as Eaton.

“Nvidia’s numbers remain extremely strong now, but there are inevitably questions whether Huang’s company has already reached its high-water mark in terms of growth and market share,” said David Russell, TradeStation’s global head of market strategy. 

In the previous session, all three major U.S. stock indexes rose across the board as investors awaited Nvidia’s report. Gains in the S&P 500 and Dow Jones Industrial Average snapped a four-day slide for both indexes. To be sure, stocks are in the red for the week given the depth of the recent pullback in several growth stocks.

Minutes from the Federal Reserve’s October meeting released Wednesday afternoon showed disagreements between Fed officials over whether a slowing labor market or inflation were bigger threats to the U.S. economy. The divide between central bank officials is also reflected in their outlook for their upcoming December decision, with “many” officials calling for no more interest rate cuts this year. Traders are pricing in a 33% likelihood that the Fed will cut its benchmark overnight borrowing rate by a quarter percentage point during its upcoming December meeting, significantly lower than their bets just a month ago, per the CME FedWatch Tool.

On Thursday morning, the Bureau of Labor Statistics will release September nonfarm payrolls data, which was delayed by the U.S. government shutdown.



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More